Trevi Therapeutics, Inc. (TRVI) Social Stream



Trevi Therapeutics, Inc. (TRVI): $2.66

0.14 (-5.16%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Featured Post From StockTwits About TRVI

$TRVI This should not be sitting at this price.

$3B+ est. PN global category in
$20B pruritus market
PRISM: Ph2b/3 study of pruritus in
PN enrollment expected to be
completed in 2H 2021 with top-line
data 1H2022
• Fast Track designation granted for
moderate to severe pruritus in PN

$4B est. IPF global category in $10B
chronic cough market
CANAL: Ph2 study of chronic cough
in IPF has restarted enrollment
post-covid, with top-line data
expected 1H2022
Bobbie_Who, published July 30, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!